Vital Signsby BridgeheadAll voices

01  Voice · Academic · Heart disease & stroke

Sanjiv Shah: no photograph is held, so the academic plate is shown instead.
Academic

Sanjiv Shah

M.D., principal investigator of the Level trial, Northwestern University

Press coverage by month · bar height shows relative volume
Aug 2026Sept 2026Oct 2026Nov 2026to date
1

Quoted in the press, across 1 topic since 10 Aug 2026

02  Quoted on · 1 of 29 topics

Open the topic

Sanjiv Shah: key facts

Kind of voice
Academic
Role
M.D., principal investigator of the Level trial, Northwestern University
Press coverage
Quoted in the press
Most recently quoted
10 Aug 2026

04  On the record · press

What Sanjiv Shah has said

By outlet · bar length shows relative volume
  • fiercepharma.com

Where Sanjiv Shah has been quoted

  1. Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA pathfiercepharma.com · 10 Aug 2026

How we found the articles that name Sanjiv Shah: we searched news for these terms.

  • heart disease
  • cardiovascular
  • stroke
  • cardiac
  • heart attack
  • stroke rehabilitation

Also searched with “heart disease” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Heart disease & stroke

Verbatim

“In my opinion, a drug that lowers wall stress and modifies cardiac structure and function this robustly is likely to be disease-modifying”
M.D., principal investigator of the Level trial, Northwestern University · Heart disease & stroke · fiercepharma.com · 10 Aug 2026 · Read the article

Related media coverage

Recent UK press coverage of their topics, not necessarily citing them directly.

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.